AbbVie (NYSE: ABBV) today announced that its board of directors has unanimously elected chief executive officer (CEO) Robert A. Michael to assume the additional position of chairman, effective July 1, ...

Robert Michael will replace former CEO Richard Gonzalez, marking the official end to Gonzalez’s long reign at the pharma ...

AbbVie is using innovative technologies like AI, wearables and automation to speed up drug discovery, clinical trials, and ...

AbbVie made a change atop its board of directors, naming CEO Robert Michael as chairman on Friday morning. The pharma giant announced that Michael will succeed Richard A. Gonzalez, the former CEO of ...

The treatment landscape of Inflammatory Bowel Disease (IBD) has undergone a significant transformation over the past two ...

Researchers identify a new player in human immunity that can go rogue and turn the immune system against the body’s own ...

Leading Estonian construction consulting and project management firm HML Project Management has officially expanded to ...

AbbVie's $10.1 billion takeover of ImmunoGen ... taking women away from precious moments with their family, disrupting careers and the many other important contributions that women make to society ...

Defense Secretary Pete Hegseth has ordered senior military and Defense Department officials to draw up plans to cut 8 percent ...

Ovarian cancer continues to pose a significant challenge in the medical field, remaining one of the leading causes of death ...

The Schwab U.S. Dividend Equity ETF is a top pick for conservative investors seeking stable returns & dividend growth. Click ...